1. Home
  2. HRTX vs TDAC Comparison

HRTX vs TDAC Comparison

Compare HRTX & TDAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HRTX
  • TDAC
  • Stock Information
  • Founded
  • HRTX 1983
  • TDAC 2022
  • Country
  • HRTX United States
  • TDAC United States
  • Employees
  • HRTX N/A
  • TDAC N/A
  • Industry
  • HRTX Biotechnology: Pharmaceutical Preparations
  • TDAC
  • Sector
  • HRTX Health Care
  • TDAC
  • Exchange
  • HRTX Nasdaq
  • TDAC NYSE
  • Market Cap
  • HRTX 270.7M
  • TDAC N/A
  • IPO Year
  • HRTX 1987
  • TDAC 2024
  • Fundamental
  • Price
  • HRTX $2.22
  • TDAC $10.08
  • Analyst Decision
  • HRTX Strong Buy
  • TDAC
  • Analyst Count
  • HRTX 3
  • TDAC 0
  • Target Price
  • HRTX $5.67
  • TDAC N/A
  • AVG Volume (30 Days)
  • HRTX 1.8M
  • TDAC 115.3K
  • Earning Date
  • HRTX 05-06-2025
  • TDAC 01-01-0001
  • Dividend Yield
  • HRTX N/A
  • TDAC N/A
  • EPS Growth
  • HRTX N/A
  • TDAC N/A
  • EPS
  • HRTX N/A
  • TDAC N/A
  • Revenue
  • HRTX $144,285,000.00
  • TDAC N/A
  • Revenue This Year
  • HRTX $11.81
  • TDAC N/A
  • Revenue Next Year
  • HRTX $15.79
  • TDAC N/A
  • P/E Ratio
  • HRTX N/A
  • TDAC N/A
  • Revenue Growth
  • HRTX 13.57
  • TDAC N/A
  • 52 Week Low
  • HRTX $1.04
  • TDAC $10.00
  • 52 Week High
  • HRTX $3.93
  • TDAC $10.20
  • Technical
  • Relative Strength Index (RSI)
  • HRTX 49.51
  • TDAC N/A
  • Support Level
  • HRTX $2.32
  • TDAC N/A
  • Resistance Level
  • HRTX $2.46
  • TDAC N/A
  • Average True Range (ATR)
  • HRTX 0.14
  • TDAC 0.00
  • MACD
  • HRTX -0.04
  • TDAC 0.00
  • Stochastic Oscillator
  • HRTX 21.59
  • TDAC 0.00

About HRTX Heron Therapeutics Inc.

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Share on Social Networks: